190
PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Embed Size (px)

Citation preview

Page 1: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PATHOLOGY OF ENDOCRINE SYSTEM 2009

Dr. Huda M Zahawi, FRC.Path

Page 2: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

The Endocrine system is divided into :

• Endocrine organs dedicated to production of hormones e.g. pituitary,thyroid….etc

• Endocrine components in clusters in organs having mixed functions e.g. pancreas, ovary, testes…..

• Diffuse endocrine system comprising scattered cells within organs acting locally on adjacent cells without entry into blood stream

Page 3: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Disease divided into :

1- Diseases of overproduction of secretion ( Hyperfunction )2- Diseases of underproduction ( Hypofunction )3- Mass effects ( Tumors )

N.B. Correlation of clinical picture , hormonal assays , biochemical findings , together with pathological picture are of extreme importance in most conditions.

Page 4: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PITUITARY GLAND

Page 5: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PITUITARY GLAND• Pituitary in sella turcica,& weighs about 0.5gm.• Connected to the HYPOTHALAMUS with stalk.• Composed of : A-ADENOHYPOPHYSIS- (80%)

– Blood supply is through portal venous plexus– Hypothalamic-Hypophyseal feed back control

B- NEUROHYPOPHYSIS – From floor of third ventricle – Modified glial cells & axons hypothalamus.– Has its own blood supply.

Page 6: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

CELLS & SECRETIONS :

A- Anterior pituitary ( Adenohypophysis )

1-Somatotrophs from acidophilic cells → Growth H.

2- Lactotrophs from chromophobe cells → Prolactin

3- Corticotrophs from basophilic cells → ACTH,MSH .

4- Thyrotrophs from pale basophilic cells → TSH 5- Gonadotrophs from basophilic cells → FSH, LH

B- Posterior pituitary ( Neurohypophysis ) 1- Oxytocin 2- ADH

Page 7: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

HYPERPITUITARISM & PITUITARY ADENOMA

In most cases, excess is due to ADENOMA

arising in the anterior lobe. Less common causes include : * Hyperplasia * Carcinoma * Ectopic hormone production * Some hypothalamic disorders

Page 8: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of pituitary adenomas :• Mutations in G-proteins ( α subunit) in the GNAS1

gene on chromosome 20q13 lead to activation• 40% of GH secreting adenomas & less in ACTH• G-proteins involved in signal transduction :

GDP GTP cAMP

• Mutations in α subunit interfere with GTPase function

• Mutations in RAS, overexpression in C- MYC & NM23 inactivation found in more aggressive tumor• Other mutations : MEN-1 gene ( Menin)

G proteins

GTPase

Page 9: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Features common to all pituitary adenomas :• 10% of all intracranial neoplasms & 25%

incidental 3% occur with MEN syndrome• 30-50 years of age • Primary pituitary adenomas usually benign• May or may not be functional• If functional, the clinical effects are secondary

to the hormone produced.• More than one hormone may be produced by

same cell• Although most are localized, invasive

adenomas erode sella turcica & extend into cavernous & sphenoid sinus

Page 10: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

CLINICAL FEATURES of PITUITARY ADENOMA:

1- Symptoms of hormone produced 2- Local mass effects : i- Radiological changes ii-Visual field abnormalities iii-Elevated intracranial pressure 3- Hypopituitarism 4- Pituitary apoplexy

Page 11: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 12: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 13: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)Mass effect of pituitary adenoma

Page 14: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology of pituitary adenomas :

• Well circumscribed,invasive in up to 30%• Size 1cm. or more, specially in nonfunctioning tumor• Hemorrhage & necrosis seen in large tumorsMicroscopic picture : • Uniform cells, one cell type (monomorphism) • Absent reticulin network• Rare or absent mitosis

Page 15: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Sella turcica with pituitary adenoma

Page 16: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

Uniform cells of pituitary adenoma

Page 17: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Types of Pituitary Adenomas

• Previously classified according to histological

picture e.g : Acidophilic Adenoma• Now according to

immunohistochemical findings & clinical picture ….. e.g. Growth hormone secreting adenoma

Page 18: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Immunoperoxidase for GH

Page 19: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

1- PROLACTINOMA :

• 30% of all adenomas, chromophobe or weakly acidophilic

• Functional even if small, but related to size• Other causes of prolactin include : estrogen

therapy, pregnancy, reserpine , hypothyroidism……

• Any mass in the suprasellar region may interfere with normal prolactin inhibition Prolactin

( STALK EFFECT )• Mild elevation of prolactin does NOT always

indicate prolactin secreting adenoma !

Page 20: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Symptoms :

• Galactorrhea• Amenorrhea• Decrease libido• Infertility

Page 21: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2- Growth hormone secreting adenoma : • 40% Associated with GNAS 1 gene mutation• Persistent secretion of growth hormone

leads to secretion of Insulin – like GF → symptoms

• Composed of granular ACIDOPHILIC cells • May be mixed with prolactin secretion.• Symptoms delayed so adenomas are usually

large • Produce GIGANTISM or ACROMEGALLY• Other symptoms : diabetes, arthritis, large

jaw & hands, osteo porosis, BP, HF…..etc

Page 22: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

3- Corticotroph cell adenoma

• Usually microadenomas• Higher chance of becoming malignant• Chromophobe or basophilic cells • Functionless or Cushing ‘s Disease ( ACTH )• Bilateral adrenalectomy or destruction may result in aggressive adenoma: Nelson’s Syndrome • Corticotroph microadenoma

Macroadenoma ICP

Page 23: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

4- Non functioning adenoma 20% silent or null cell ,nonfunctioning & produce mass effect only

5- Gonadotroph producing LH &FSH- ( 10-15%)- Function silent or is minimal , late presentation mainly mass effect produced.

Produce gonadotrophin α subunit, β- FSH & β-LH

6- TSH producing ,(1%) rare cause of hyperthyroidism

7- Pituitary carcinoma - Extremely rare, diagnosed only by metastases.

Page 24: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

HYPOPITUITARISM : • Loss of 75% of ant. Pituitary Symptoms • Congenital or acquired, intrinsic or extrinsic• Symptoms include dwarfism, & effect of

individual hormone deficiencies. Loss of MSH → Decreased pigmentation

• Acquired causes include : 1- Nonsecretory pituitary adenoma 2- Ischemic necrosis e.g.

SHEEHAN’S SYNDROME (post partum hmg.) sickle cell anemia, DIC, Pituitary apoplexy…

3- Iatrogenic by radiation or surgery 4- Autoimmune ( lymphocytic) hypophysitis 5- Inflammatory e.g sarcoidosis or TB …..

Page 25: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

6- Empty Sella Syndrome : Radiological term for enlarged sella tursica, with atrophied or

compressed pituitary. May be primary due to downward

bulge of arachnoid into sella floor compressing pituitary.

Secondary is usually surgical. 7- Infiltrating diseases in adjacent bone

e.g. Hand Schuller – Christian Disease

8- Craniopharyngioma

Page 26: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Craniopharyngioma :

* 1-5 % of intracranial neoplasms * Derived from remnants of Rathke’s Pouch * Suprasellar or intrasellar ,often cystic with calcification * Children or adolescents most affected * Symptoms may be delayed ≥ 20yrs( 50%) * Symptoms of hypofunction or hyperfunction of pituitary and /or visual disturbances, diabetes insipidus * Benign & slow growing

Page 27: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

POSTERIOR PITUITARY SYNDROMES:

1-A- ADH deficiency causes Diabetes Insipidus Excessive urination,dilute urine , due to inability to reabsorb water from the collecting tubules. Causes include head trauma, tumors & inflammations in

pituitary or hypothalamus…etc. B- Syndrome of inappropriate ADH secretion Causes excessive resorption of water hyponatremia e.g Small Cell CA of Lung

Page 28: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2-Abnormal oxytocin secretion :

Abnormalitis of synthesis & release have not been associated with any significant abnormality.

Page 29: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

THYROID GLAND

Page 30: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Development from evagination of pharyngeal tissue into neck

• Abnormal descent Lingual thyroid , subhyoid, substernal

• Weight 15-20gm. Responsive to stress• Structure : varying sized follicles lined by columnar epithelium , filled with colloid, interfollicular C cells• Secretion of T3 & T4 is controlled by

trophic factors from hypothalamus & ant.pituitary

Page 31: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

THYROTOXICOSIS:

• Hypermetabolic state caused by T4, T3. A- Associated with hyperthyroidism:

Primary : Graves Disease Toxic multinodular goiter Toxic adenoma

Secondary : TSH secreting pit. adenoma

B- Not associated with hyperthyroidism : Thyroiditis Struma ovarii Exogenous thyroxine intake

Page 32: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Clinical Picture related to Sympathetic Stimulation

• Constitutional symptoms : heat intolerance, sweating, warm skin, appetite but ↓weight

• Gastrointestinal : hypermotility, malabsorption

• Cardiac : palpitation, tachycardia, CHF

• Menstrual disturbances

Page 33: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Neuromuscular : Tremor, muscle weakness

• Ocular : wide staring gaze, lid lag, thyroid ophthalmopathy

• Thyroid storm : severe acute symptoms of sympathetic overstimulation

• Apathetic hyperthyroidism : incidental

Page 34: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 35: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Diagnosis of Hyperthyroidism :

• Measurement of serum TSH (↓ ) + free T4 is the most useful screening test for thyrotoxicosis

• TSH level is normal or in secondary thyrotoxicosis

• In some patients , T3 but T4 normal or ↓

• Measurement of Radioactive Iodine uptake is a direct indication of activity inside the gland

Page 36: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Normal radioactive I uptake

Page 37: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

HYPOTHYROIDISM :

Primary : 1- Loss of thyroid tissue due to surgery or radiation Rx. 2- Hashimoto’s thyroiditis 3- Iodine deficiency specially in endemic areas 4- Primary idiopathic hypothyroidism 5- Congenital enzyme deficiencies 6- Drugs e.g. iodides, lithium….. 7- Thyroid dysgenesis ( developmental )

Secondary : Pituitary or hypothalamic failure

Page 38: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Hypothyroidism is commoner in endemic areas of iodine deficiency

CRETINISM : hypothyroidism in infancy & is related to the onset of deficiency .

If early in fetal life Mental retardation , short stature, hernia, skeletal abnormalities,

MYXEDEMA in adults Apathy, slow mental processes, cold intolerence,accumulation of mucopolysaccharides in subcutaneous tissue

Lab.tests : TSH in primary hypothyroidism, unaffected in others T4 in both.

Page 39: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

THYROIDITIS :

• Mostly autoimmune mechanisms• Microbial infection is rare• Types include : 1- Chronic lymphocytic ( Hashimoto’s ) thyroiditis 2- Subacute granulomatous ( de Quervain) thyroiditis 3- Subacute lymphocytic thyroiditis 4- Riedel thyroiditis 5- Palpation thyroiditis

Page 40: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

HASHIMOTO’s THYROIDITIS : Chronic Lymphocytic Thyroiditis

• Autoimmune disease characterized by progressive destruction of thyroid tissue

• Commonest type of thyroiditis• Commonest cause of hypothyroidism in

areas of sufficient iodine levels• F:M = 10-20 :1, 45-65 yrs.• Can occur in children

Page 41: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis :

A - T cell sensitization to thyroid antigens 1- Sensitized CD4 T cells Cytokine mediated ( IFN- γ)cell death

inflammation,macrophage activation 2- CD8+ cytotoxic T cell mediated cell death: Recognition of AG on cell killed 3- Presence of thyroid AB Antibody

dependent cell mediated cytotoxicity by NK cells

B- Genetic predisposition : ↑ in relatives of 1st.degree Association with HLA – DR 3 & DR- 5

Page 42: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology:

• Gland is a smooth pale goitre, minimally nodular, well demarcated.

• Microscopically : - Dense infiltration by lymphocytes & plasma cells - Formation of lymphoid follicles, with germinal centers - Presence of HURTHLE CELLS - With or without fibrosis

Page 43: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Clinically :

– Painless symmetrical diffuse goiter– May show initial toxicosis

( Hashitoxicosis ).

– Later marked hypothyroidism.– Patients have risk of B-Cell

lymphoma

Page 44: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 45: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

SUBACUTE GRANULOMATOUS THYROIDITIS :• Middle aged , more in females. Viral etiology

?• Self-limited (6-8w)• Acute onset of pain in the neck , fever, ESR, WBC• Transient thyrotoxicosis.• Morphology :

– Firm gland. – Destruction of acini leads to mixed inflammatory infiltrate.– Neutrophils , Macrophages & Giant cells & formation of granulomas

Page 46: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

SUBACUTE LYMPHOCYTIC THYROIDITIS : (Silent)• Middle aged females & post partum patients

• Probably autoimmune with circulating AB

• May recur in subsequent pregnancies

• May progress to hypothyroidism

• Histology similar to Hashimoto’s thyroiditis without Hurthle cell metaplasia

• Reidel’s Thyroiditis –

Dense fibrosis without prominent inflammation

? Considered as fibromatosis rather than thyroiditis

Page 47: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 48: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

GRAVE’S DISEASE :

• Commonest cause of endogenous hyperthyroidism

• Age 20- 40 yrs., • M: F ratio is 1: 7• More common in western races

Page 49: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Main features of GRAVES DISEASE :

1 - Thyrotoxicosis with smooth symmetrical enlargement of thyroid 2 - Infiltrative ophthalmopathy with exophthalmus in 40% 3- Pretibial myxedema in a minority

• Lab findings : T4, T3 , TSH• Radioactive study: Diffuse uptake of

radioactive I

Page 50: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of GRAVE’S DISEASE :

• Genetic etiology + Autoimmune processes• GENETIC EVIDENCE :• May be familial • 60% concordance in identical twins• Susceptibility is associated with HLA-B8 & - DR3 • May exist with other similar diseases e.g. SLE, Pernicious anemia, Diabetes type I, Addison’s dis.

Page 51: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

IMMUNE MECHANISMS :

• Antibodies to thyroid peroxisomes & thyroglobulin• Patients develop autoantibodies to TSH receptor

– Thyroid Stimulating Immunoglobulin ( TSI) binds to TSH receptor → thyroxin ***

– Thyroid Growth Stimulating Immunoglobulin (TGI) → proliferation of thyroid epithelium – TSH binding inhibitor immunoglobulins (TBIIs) prevent TSH from binding to receptor

• Both stimulation & inhibition may coexist

Page 52: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology :

• Smooth enlargement of gland with diffuse hyperplasia & hypertrophy

• Lining epithelium of acini : Tall & hyperplastic ± papillae• Colloid : Minimal thin colloid with scalloped

edge

Page 53: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 54: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Changes in Extrathyroid tissue :

• Generalized lymphoid hyperplasia • Ophthalmopathy : Edematous orbital muscles &infiltration by lymphocytes followed by fibrosis

• Thickening of skin & subcutaneous tissue

• Accumulation of glycosaminoglycans which

are hydrophilic

Page 55: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Result : Displacement of eyeball &

exophthalmus → redness, dryness, ulceration, infection in conjunctiva

• Cause : Expression of aberrant TSH receptor

responding to circulating anti TSH receptor AB → inflammatory lymphocytic reaction

Page 56: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 15 December 2005 07:30 AM)

© 2005 Elsevier

Page 57: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

DIFFUSE NONTOXIC & MULTINODULAR GOITRE GOITER = Enlargement of thyroid Most common cause is iodine

deficiency impaired hormone synthesis TSH hypertrophy & hyperplasia of follicles Goiter

Endemic : 10% of population have goiter

Sporadic : 1- Physiological demand 2- Dietary intake of excessive calcium & cabbages…etc 3- Hereditary enzyme defects

Page 58: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

MORPHOLOGY :

• Initially diffuse → nodular with degenerative changes: colloid cysts, hemorrhage, fibrosis, calcification

• If large may extend retrosternally• Pressure symptoms are a common

complaint• Picture is that of varying sized follicles,

hemorrhage , fibrosis , cysts, calcification • Patient is often EUTHYROID. but may be

toxic or hypofunctioning.

Page 59: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 60: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Normal radioactive I uptake

Page 61: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 62: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 63: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 64: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

NODULES in the thyroid :• Nodules in thyroid may be multiple or

solitary

• Any solitary nodule in the thyroid has to be investigated as some are neoplastic. Investigations include FNA , Radioactive image

technique, Ultrasound, & (T4,T3 & TSH ) levels • HOT nodule takes up radioactive substance ( functional)• COLD nodule does not it take up ( nonfunctional )

Page 65: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 66: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 67: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

General rules of nodules in the thyroid :

1- Solitary nodule is MORE likely to be NEOPLASTIC than multiple

2- Hot nodules are more likely to be BENIGN

3- Not every cold nodule is malignant . Many are nonfuctioning adenomas, or

colloid cysts , nodules of nodular goitre….etc Up to 10% of cold nodules prove to be malignant.

Page 68: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

4- Nodules in younger patients are more likely to be NEOPLASTIC

5- Nodules in males are more likely to be NEOPLASTIC .

6- History of previous radiation to the neck is associate with increased risk of malignancy

Page 69: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

NEOPLASMS of the THYROID :

ADENOMAS:• Usually single.• Well defined capsule• Commonest is follicular± Hurthle cell

change • May be toxic• Size 1- 10cm. Variable colour • Activating somatic mutation in TSH receptor

is identified leading to overproduction of cAMP

• 20% have point mutation in RAS oncogene

Page 70: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Microscopical Picture :

• 1- Uniform follicles , lined by cuboidal epithelial cells. • 2- Focal nuclear pleomorphism, nucleoli …. ( Endocrine atypia )• 3- Presence of a capsule with tumor compressing surrounding normal thyroid outside . * Integrity of capsule is important in differentiating

adenoma from well differentiated follicular carcinoma.

• Capsular and/ or vascular invasion →Carcinoma

Page 71: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 72: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

© 2005 Elsevier Adenoma with intact capsule

Page 73: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Capsular invasion)

Page 74: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

CARCINOMAS of THYROID :

• Incidence about 1-2% of all malignancies.• Wide age range ,depending on type.• Generally commoner in females, but in

tumors occurring in children or elderly , equal incidence in both sexes.

• Most are derived from follicular cells• Few are derived from ‘C’ cells

Page 75: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

TYPES of THYROID CARCINOMA :

1- Papillary Carcinoma ( 75- 85% ),any age,but usual type in children.

2- Follicular Carcinoma ( 10- 20% )More in middle age

3- Medullary Carcinoma ( 5% ) age 50-60 but younger

in familial cases with MEN syndrome 4- Anaplastic Carcinoma ( 5% ) , old age Presenting symptom is usually a mass , maybe

incidental in a multinodular goitre specially papillary, & follicular

Page 76: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of Thyroid Cancer :

1- Genetic lesions : Most tumors are sporadic Familial is mostly Medullary CA , Papillary CA• Papillary CA :

– Chromosomal rearrangement in tyrosin kinase receptor gene (RET) on chr.10q11

ret/PTC tyrosine kinase activity ( 1/5 of cases specially in children)– Point mutation in BRAF oncogene (1/3-1/2)

Page 77: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Follicular Carcinoma :– RAS mutation in ½ of cases OR– PAX8- PPAR γ 1 fusion gene in 1/3 of

cases• Medullary Carcinoma :

– RET mutation Receptor activation• Anaplastic Carcinoma :

– Probably arising from dedifferentiation of follicular or papillary CA inactivation of P53

Page 78: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2- Environmental Factors :• Ionizing radiation specially in first two decades• Most common is Papillary CA. with

RET gene rearrangement3- Preexisting thyroid disease :• Incidence of thyroid CA is more in

endemic areas• Long standing multinodular goiter →

Follicular CA• Hashimotos thyroiditis → Papillary CA &

B cell lymphoma

Page 79: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• TYPES OF THYROID CARCINOMAS

Page 80: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PAPILLARY CARCINOMA :

• Cold on Scan by radioactive Iodine

• Solitary or multifocal

• Solid or cystic, calcification

• Composed of papillary architecture

• Less commonly ‘Follicular Variant’

Page 81: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 82: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Diagnosis based on NUCLEAR FEATURES

• Nuclei are clear (empty) ,with grooves & inclusions ( Orphan Annie nuclei)

• Psammoma bodies• Metastases mainly by L.N., sometimes

from occult tumor• Hematogenous spread late & prognosis is GOOD

Page 83: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier FNA of Papillary CA (nuclear changes)

Page 84: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 85: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Psammoma body in Papillary CA

Page 86: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

FOLLICULAR CARCINOMA :

• Usually cold but rarely functional ( warm )

• Well circumscribed with thick capsule (minimally invasive) or diffusely infiltrative

• Composed of follicles , sometimes of Hurthle Cells

• Diagnosis is based on CAPSULAR & VASCULAR invasion

Page 87: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Metastasize usually by blood Lungs, Bone, Liver ..etc.

• Treatment by surgery Radioactive Iodine Thyroxin

• Prognosis is not as good as papillary except in minimally invasive very well differentiated forms

Page 88: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Follicular Carcinoma

Page 89: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Capsular invasion)

Page 90: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

MEDULLARY CARCINOMA:

• Arise from C cells CALCITONIN, CEA, serotonin, VIP

• 80% Sporadic , or familial MEN Syndrome

• Composed of polygonal or spindle cells , usually with demonstrable AMYLOID in the stroma

• Calcitonin demonstrated in tumor cells

Page 91: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Level of calcitonin in serum may be useful for follow up

• Family members may show C cell hyperplasia ,↑ Calcitonin, & RET mutation

( Marker for early diagnosis)

• Metastases by blood stream

• Prognosis intermediate , worse in MEN. 2B

Page 92: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Medullary CA with amyloid

Page 93: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Congo red for amyloid

Page 94: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ANAPLASTIC CARCINOMA :

• Elderly patients with multinodular goitre in 50%

• Foci of papillary or follicular CA may be present in 20%- 30% , probable dedifferentiation process

• Markedly infiltrative tumor , invading the neck → pressure on vital structures

• Rapid progression, death within 1 year

Page 95: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Morphology : Composed of pleomorphic giant cells, spindle cells or small cell anaplastic varients, which may be confused with lymphoma

• Radiosensitive tumor , no surgery

• P53 mutation identified , consistent with tumor progression

Page 96: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PARATHYROID GLAND

• Derived from the third and fourth pharyngeal pouches.• 90% of people have four glands.• Location: mostly close to the upper or lower poles of

the thyroid.• Can be found anywhere along the line of descent of

the pharyngeal pouches.• There are two types of cells with intervening fat : - Chief & Oxyphil cells• Secretion of PTH is controlled by level of free calcium

Page 97: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Hyperparathyroidism : Primary OR Secondary

Primary Hyperparathyroidism:• Commonest cause of asymptomatic hypercalcemia• Female:Male ratio = 2-3 : 1.• Causes : Adenoma 75%-80% Hyperplasia 10-15% Carcinoma < 5%• Majority of adenomas are sporadic• 5% familial associated with MEN-1 or MEN-2A

Page 98: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Genetic abnormalities :

• PRAD 1 on chromosome 11 q cell cycle control cyclin D1 overexpression(10%-20%)

• MEN 1 on 11q13 is a cancer suppressor gene- Germ line mutation in MEN-1 syndrome loss of function cell proliferation- *20% - 30% of sporadic cases may also show mutation of MEN1*Either of above may cause tumor or hyperplasia

Page 99: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Biochemical findings : PTH , Ca , ↓ phosphate ,alkaline

phosphatase

• In other causes of hypercalcemia, PTH is ↓

Page 100: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Gland morphology in Hyperparathyroidism

•Adenomas :• Usually single , rarely multiple • Well circumscribed, encapsulated

nodule (0.5-5g.) • The cells are polygonal, uniform chief

cells, few oxyphil cells. Adipose tissue is minimal in the tumor

• Compressed surrounding parathyroid tissue in periphery, other glands normal or atrophic .

Page 101: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 102: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

•Hyperplasia : Enlargement of all 4 glands. Microscopically chief cell hyperplasia,

or clear cell, usually, in a nodular or diffuse pattern.

Note : Diagnosis of adenoma versus hyperplasia may depend on the size of the other glands

Page 103: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Parathyroid carcinoma :

• Larger than adenoma (5-10g) • Very adherent to surrounding tissue.• Pleomorphism & mitoses not reliable

criteria for malignancy • Most reliable criteria for malignancy

are : * Invasion **Metastases

Page 104: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology in other organs:

• Skeletal system:– Bone resorption by osteoclasts, with fibrosis,

cysts formation and hemorrhage Osteitis Fibrosa Cystica

– Collections of osteoclasts form ‘ Brown Tumors”

– Chondrocalcinosis and pseudogout may occur.

• Renal system:– Ca. Stones. & Nephrocalcinosis.

• Metastatic calcification in other organs: Blood vessels & myocardium , Stomach, Lung

…etc

Page 105: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Hyperparathyroidism, clinical picture

• 50% of patients are asymptomatic.• Patients show Ca & PARATHORMONE levels in

serum• Symptoms and signs of hypercalcemia: Musculoskeletal, Gastrointestinal tract, Urinary

and CNS symptoms • Commonest cause of silent hypercalcemia .• In the majority of symptomatic hypercalcemia

commonest cause is wide spread metastases to bone

Page 106: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Painful Bones, Renal Stones, Abdominal Groans & Psychic Moans

Page 107: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Secondary Hyperparathyroidism :

• Occur in any condition associated with chronic hypocalcemia, mostly chronic renal failure.

• Glands are hyperplastic

• Renal failure phosphate excretion increased serum phosphate, CaPTH

Page 108: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Tertiary Hyperparathyroidism

• Extreme activity of the parathyroid

autonomous function & development of adenoma (needs surgery)

Page 109: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Hypoparathyroidism :

• Causes:– Damage to the gland or its vessels

during thyroid surgery.– Idiopathic, autoimmune disease.– Pseudohypoparathyroidism, tissue resistance to PTH

• Clinical features: -Tetany, convulsion, neuromuscular irritability, cardiac arrhythmias……

Page 110: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ENDOCRINE PANCREAS

Page 111: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Diseases mainly include :

– Diabetes– Islet Cell Tumors

Page 112: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

DIABETES

Page 113: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

DIABETES :

• Chronic disorder in which there is abnormal metabolism, of carbohydrate, fat & protein , characterized by either relative or absolute insulin deficiency, resulting in hyperglycemia.

• Most important stimulus that triggers insulin synthesis from β cells is GLUCOSE

• Other agents stimulate insulin release• Level of insulin is assessed by the level of C - peptide

Page 114: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Diagnosis :

1- Random glucose ≥ 200g / dL + symptoms

2- Fasting glucose of ≥ 126 / dL on more than one occasion 3- Abnormal OGTT when glucose level is more than 200g / dL 2hrs. after

standard glucose load of 75 g.

Page 115: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Classification : Causes could be Primary in the pancreas

OR secondary to other disease conditions

Primary diabetes is classified into : A- Type 1 B- Type 2 C- Genetic & Miscellaneous causes

Whatever the type, complications are the same

Page 116: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Type 1 :-

• Absolute deficiency of insulin due to β cell destruction ( 10%)

• 90% of cells lost before metabolic changes appear

• Age ≤ 20 yrs but may be latent• Normal or decreased weight• Ketoacidosis is common

Page 117: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Type 2 :

• Due to a combination of peripheral resistance to insulin action & inadequate secretory response by the pancreatic β cells

• Commoner ( 80 - 90% )• Insulin normal (relative insulin

deficiency) • Patient is overweight• Rare ketoacidosis

Page 118: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Type 3 : Miscellaneous causes

• Genetic defects :– β cell function e.g. Maturity Onset Diabetes of the Young ( MODY)caused by a variety of

mutations

– Genetic defects of insulin processing or action

e.g. Insulin gene or Insulin receptor mutations

Page 119: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Secondary Miscellaneous Causes :

• Diseases of exocrine pancreas e.g. chronic pancreatitis

• Endocrinopathies e.g. Cushing’s Syndrome,

Acromegally• Infections e.g. CMV• Drugs e.g. glucocorticoids• Gestational diabetes• Other genetic syndromes associated

with diabetes

Page 120: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PATHOGENESIS

Page 121: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of Type 1 Diabetes :

1- Genetic susceptibility2- Autoimmunity 3- Environmental factors

It is a combination of autoimmunity & environmental insult in a person with a known genetic susceptibility leading to destruction of β cells

Page 122: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

1- Genetic susceptibility

– Principal susceptibility genes located in region of MHC class II on chromosome 6p21

– 90% Associated with HLA- DR3,or HLA- DR4, or both

– Racial predisposition, (Caucasians) but majority have no family history

– 6- 20% familial ,< 40% in identical twins – Second susceptibility gene encodes a T cell inhibitory receptor (CTLA-4) interfering

with normal T cell function

Page 123: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2- Autoimmunity -

• Presence of CD 8+ & CD 4+ in islet cells “ Insulinitis”• Presence of islet cell antibodies ( insulin

& GAD) in 80% of patients & in relatives several months or years before onset

• Antibodies are highly selective against β cells

• Relatives at risk have similar AB years before onset

• 10% - 20% other autoimmune disease

Page 124: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

3- Environmental factors

An environmental insult may damage β cells

rendering them antigenic.

• Viruses : measles , coxsackie , rubella

• Chemicals• Cow’s milk

Page 125: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of Type 2 diabetes :

1- Genetic factors 2- Insulin resistance & obesity 3 - cell secretion dysfunction

Page 126: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

1- Genetic factors :

– Genetic factors are more important than in type 1 diabetes, but this is multifactorial– 50% - 90% in identical twins risk by 20%-40% in first degree relatives– No association with HLA & no autoimmune

basis– Point mutation in insulin receptor identified

affecting signaling pathway but rare ( 1-5%)

Page 127: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2 – Insulin resistance :

• Decrease ability of peripheral tissue to respond to insulin

Early : insulin resistance → insulin secretion due to compensatory of cell

mass Later : relative insulin & cell mass

to 20-50%MAIN FACTOR IN INSULIN RESISTANCE IS

OBESITY

Page 128: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Explanation :

• Adipocytokines :

– Resistin ↑ obesity → Insulin resistance– Leptin & Adiponectin contribute to

insulin sensitivity but are ↓in obesity → resistance

– PPAR γ is a nuclear receptor that regulates level of adipocytokines

– FFA in tissues (lipotoxic effect) → insulin resistance

Page 129: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

3- cell Dysfunction :

• Defective glucose recognition due to ↑ intracellular levels of a mitochondrial protein ( UCP2) in β cells

• Amylin :

A protein normally produced by cells secreted with insulin in response to food ingestion

Amylin accumulates outside cells, forming amyloid like deposits & may impair cell glucose sensing.

Seen in up to 90% of cases of Type II diabetes

Page 130: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathogenesis of complications :1- Nonenzymatic glycosylation of

proteins Glucose + Free amino acids Later → Irreversible combination Advanced Glycosylation End products

=AGES Measured by level of glycosylated Hb ( HbA1c) AGES inactivate proteins & cross link with more proteins, deposited in vessels, renal glomeruli, …..etc

Page 131: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Effects :

Induce cytokine production, GF :• ↑ vascular permeability• ↑ procoaggulant activity• ↑ fibroblasts & SM in ECM

Complications in blood vessels, kidney, nervous system ….etc

Complications are proportional to the degree

of hyperglycemia of whatever type

Page 132: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

2- The Polyol Pathway

Persistent hyperglycemia facilitates entry of glucose & its accumulation into some cells & metabolized into

SORBITOL (a polyol) & FRUCTOSE Creation of osmotic gradient Influx

of fluid + Toxic lens, retina, peripheral nerves,

kidney…etc

Page 133: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

3- Activation of Protein Kinase C :

• Activation of signal transduction• Leads to production of pro-angiogenic

factors (VEGF) Important in retinal neovascularization• Production of pro-fibrogenic factors →

↑ECM & BM thickening

Page 134: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

COMPLICATIONS

Page 135: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Pathology in the Pancreas

i -Type I : - Leukocytic infiltration of islets ( T cells) ‘Insulinitis’ with progressive depletion of cells. - Later small indistinct or absent islets.

ii - Type II : - Ill defined reduction in islet cell mass - Fibrous tissue accumulation in some islets - Amyloid deposition in islets

• Newborn of diabetic mother : islet cell hyperplasia

Page 136: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 137: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 138: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

COMPLICATIONS

Page 139: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

1- Atherosclerosis : - Cardiovascular - CNS complications - Peripheral circulation 2- Diabetic microangiopathy - Hyaline arteriolosclerosis , exaggerated in hypertension - Diffuse thickening in capillaries of skin, retina peripheral nerves, renal medulla → Leaky vessels→ nephropathy, retinopathy, neuropathy

Page 140: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

3- Diabetic nephropathy

I - Glomerular lesions- - Capillary BM thickening

- Nodular glomerulosclerosis 15% -30% ( Kimmelstiel - Wilson lesion) - Diffuse mesangial sclerosis

II - Renal vascular lesions

- Renal atherosclerosis - Hyaline arteriolosclerosis

Page 141: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Kimmelstiel- Wilson lesion

Page 142: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

III – Pyelonephritis

- Acute & chronic interstitial inflammation

- Necrotizing papillitis / papillary necrosis

Page 143: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 144: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

4- Ocular complications : I - Retinopathy :

- Nonproliferative : hemorrhage, exudate, microaneurysm, edema…

- Proliferative : Neovascularization, fibrosis, retinal detachment

II - Cataract formation III - Glaucoma

Page 145: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

5- Diabetic neuropathy I - Peripheral sensory & autonomic nerve dysfunction ( microangiopathy & demyelination ) II - Neuronal degeneration III - Degenerative spinal cord lesions

6- Recurrent infections : Bacterial & mycotic

Page 146: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

•Clinical Features in Diabetes : Type 1 :• Age < 20 , but some are latent (LADA)• May present with metabolic acidosis,

weight loss, dehydration,& electrolyte imbalance.

Polyuria , Polydipsia, Polyphagia ( 3P’s) • Findings : - Hyperglycemia - Glucosuria ± Ketonuria - Electrolyte imbalance

Page 147: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Type 2 :

• Age > 40yrs., often present incidentally • Patients may have the 3 P’s

symptoms of complications• Hyperosmolar nonketotic coma caused

by dehydration due to uncompensated hyperglycemic diuresis.

• No keto acidosis • Increased susceptibility to infections

Page 148: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ISLET CELL TUMORS

Page 149: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Islet Cells & Secretions :

• β cells insulin• α cells glucagon• δ cells somatostatin• Pancreatic polypeptide ( PP) VIP

Page 150: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Islet Cell Tumors of Pancreas :• Include insulinomas, gastrinomas, glucagonomas….etc• Less frequent than pancreatic CA• Maybe functioning or nonfunctioning• Tumors ≤ 2 cm. diameter likely to be

benign• Associated clinical syndromes : 1- Hyperinsulinism (Insulinomas)

2- Zollinger - Ellison Syndrome ( Gastrinomas) 3- Multiple endocrine neoplasia (MEN)

Page 151: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Insulinoma :

• Commonest type• Hypoglycemia ≤ 50 mg./dl.• Attack precipitated by fasting or exercise, relieved by

eating or glucose administration• Lab. : serum glucose , serum insulin• Most tumors in pancreas but can be ectopic• Most tumors solitary ( < 2cm.), can be multiple• Majority are benign, 10% can be malignant• Histologically difficult to diagnose malignancy

Page 152: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Gastrinomas :

• More in middle aged females• Located in pancreas , duodenum or peripancreatic

tissue• Single or multiple, or associated with other tumors• > 50% locally invasive or have metastasized at

diagnosis• Present with Zollinger- Ellison Syndrome

Page 153: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Zollinger - Ellison Syndrome :

– Peptic ulcer disease– Ulcer features : Multiple ulcers Unusual locations specially jejunum Intractable– Gastrin hypersecretion– Diarrhea in > 50% & may be the presenting symptom

Page 154: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Rare tumors :

• α- Cell tumors : Middle aged women Glucagon secretion , mild diabetes,

skin rash, anemia• δ- Cell tumors : Somatostatin secretion

Diabetes, malabsorption, GB stones…• VIPomas : VIP secretion Watery diarrhea, hypokalemia,

achlorhydria

Page 155: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ADRENAL GLAND

Page 156: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ADRENAL GLAND

• Weight of normal gland is 4 gm. Adrenal Cortex - Derived from mesoderm & composed

of 1- Zona glomerulosamineralocorticoids (aldosteron) 2- Zona fasciculata glucocorticoids ( cortisol ) 3- Zona reticularis estrogens & androgens

• Diseases are those of hyperfunction & hypofunction & tumors

Page 157: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Adrenal Medulla – • Derived from neural crest & is part of sympathetic system. • Composed of Chromaffin cells secreting catecholamines• Diseases are mainly tumors

Page 158: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Congenital Anomalies

• Incidental finding of adrenal tissue in the inguinoscrotal path , mainly in males

• Fusion of adrenals• Congenital adrenal hyperplasia• Ectopic tissue in adrenal : liver, thyroid & ovarian

tissue

Page 159: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ADRENOCORTICAL HYPERFUNCTION :

• There are 3 syndromes associated with hyperfunction:

1- Cushing’s Syndrome & Cushing’s Disease

2- Conn’s Syndrome & Hyperaldosteronism

3- Adrenogenital Syndrome

Page 160: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

CUSHING’Syndrome

• Elevation of cortisol level , which occurs in one of four ways

A- Endogenous causes :

i- ACTH*secreting pituitary microadenoma, few macroadenomas, OR hyperplasia (CUSHING’s DISEASE) ii-Adrenal tumor or hyperplasia iii- Paraneoplastic syndrome

Page 161: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

B- Exogenous cause : Steroid Therapy

Tests used are : Level cortisol in plasma,or excretion of 17hydroxy

steroids in urine, diurnal pattern , level of ACTH, & Dexamethasone Suppression test.

Page 162: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology of adrenals in Cushing’s Syndrome :• This depends on the cause : 1- Exogenous increase glucocorticoids ACTH Bilateral atrophy of adrenals 2 -Endogenous hypercorticolism: a- Presence of adrenal adenoma or carcinoma, with atrophy of adjacent & contralateral adrenal b- Secondary to ACTH secreting adenoma bilateral diffuse or nodular hyperplasia c- Primary adrenal nodular hyperplasia

Page 163: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 164: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

The pituitary in all forms of Cushing’s syndrome showsAlteration in ACTH producing cells :

• Granular basophilic cells show lighter homogenized cytoplasm due to accumulation of intermediate keratin filaments in cytoplasm , called :

• Crooke’s Hyaline Change

Page 165: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Clinical features of Cushing’s syndrome :

Main symptoms include : Central obesity/ moon face Hypertension Hirsutism/ menstrual disturbances Diabetes Osteoporosis Increased risk of infections Pigmentation of skin

Page 166: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path
Page 167: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

HYPERALDOSTERONISM :

• Excess level of aldosterone cause sodium retension, potassium excretion, resulting in hypertension & hypokalemia.

• Type could be primary OR secondary

Page 168: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

A- Primary : Conn Syndrome• Caused by Adenoma (80%) F:M is 2:1 Single or multiple• Or primary adrenal hyperplasia ( 15% ) , • Carcinoma is rare

• Adjacent adrenal cortex is NOT atrophic• There is aldosteron Na retention & K excretion BP , Hypokalemia , RENIN Correctable cause of HYPERTENSION

Page 169: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

B- Secondary : Due to decreased renal perfusion, activation of the renin - angiotensin system aldosteron

• Differentiate from primary by RENIN

Page 170: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

VIRILIZING Syndromes : Could be caused by - primary gonadal disorders - Adrenocortical Neoplasms - Congenital adrenal hyperplasia• Neoplasms can occur at any age, frequently malignant• Congenital adrenal hyperplasia is caused by an enzyme

defect in cortisol synthesis (21 hydroxylase) NO CORTISOLACTH androgenic steroids • Virilization , precocious puberty, ambiguous genitalia• Patients have risk for acute adrenocortical insufficiency

Page 171: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 172: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

MORPHOLOGY in ALL ADRENAL TUMORS:

• Encapsulated , usually yellow• Size variable 1-2 cm. ( 30gms.)Up to large tumors • Most incidental nonfunctioning tumors, may be

functioning • Malignant tumors with necrosis, hemorrhage (≥

300gms)• Usually larger , more aggressive in adults • Both may show same appearance of uniform or slightly pleomorphic cells ,may be eosinophilic or clear• Local invasion ,& the presence of metastases

differentiate benign from malignant tumors

Page 173: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Cortical Adenoma

Page 174: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Adrenocortical carcinoma

Page 175: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

ADRENOCORTICAL INSUFFICIENCY :

• May be primary adrenal or secondary to destruction of the pituitary as in SHEEHAN’s syndrome….etc

• Primary in adrenal may be : A- Acute : 1- Massive adrenal hemorrhage as in anticoaggulant therapy, DIC, sepsis by N.meningitidis,pseudomonas ( Waterhouse- Friderichsen syndrome) 2- Sudden withdrawal of steroid therapy 3- Stress in a pt.with underlying chronic insufficiency

Page 176: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Adrenal hemorrhage

Page 177: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier

Page 178: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Adrenal insufficiency (continued )

B- Chronic :( Addison’s disease ) Progressive destruction of the adrenal by : 1- Autoimmune Disorder: 75-90 % , may be sporadic or familial, linked to HLA-B8 , DR3, HLA-DQ5 Often multisystem involvement 2- Infections e.g. Tuberculosis , fungii ( AIDS)

3- Metastatic tumors destroying adrenal e.g. lung, breast , …others

Page 179: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Morphology & Clinical features in Chronic Adrenal Insufficiency :

• Morphology depends on cause :

• Autoimmune : Irregular small glands, cortex infiltrated by lymphocytes, medulla normal.• T.B. Caseating Granuloma• Metastatic disease Type of primary tumor• Secondary to pituitary cause : the adrenal is shrunken

Page 180: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

• Clinical features :

Weight loss, hypotension, hypoglycemia, pigmentation….

There is Hyperkalemia & Hyponatremia due to ↓ mineralocorticoids

Page 181: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

THE ADRENAL MEDULLA :

• Composed of CHROMAFFIN CELLS & nerve endings • Secretetes cholamines in response to sympathetic

stimulation• Also present in extra-adrenal sites

• Pathology includes tumors : A- Pheochromocytoma B- Neuroblastoma

Page 182: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

PHEOCHROMOCYTOMA :• Secretes catecholamines → VMA• Sometimes described as The 10% Tumor because :

* 10% bilateral * 10% extra adrenal ( Paraganglioma) * 10% familial, maybe part of MEN syndrome * 10% Malignant

• Usually well circumscribed,small to large in size,maybe pleomorphic. Malignancy confirmed by METASTASES

• Clinically sustained or paroxysmal attacks of BP• CORRECTABLE cause of HYPERTENSION

Page 183: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 4 December 2005 01:50 PM)

© 2005 Elsevier Pheochromocytoma

Page 184: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

NEUROBLASTOMA :

• Commonest extracranial solid tumor of childhood• Usually adrenal but maybe extra-adrenal• Familial or sporadic• Associated with deletion of short arm of chromosome 1• 90% associated with catecholamine secretion• VMA excreted in 24 hr. urine helpful in diagnosis.• Morphologically it is composed of small round blue cells

which may differentiate to ganglion cells• Spread to adjacent organs, lymph nodes, renal vein.• Prognosis : STAGE , AGE , N myc amplification

Page 185: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

MULTIGLANDULAR SYNDROMES

Page 186: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

POLYGLANDULAR SYNDROME :

• Autoimmune disease• Familial or sporadic

– Isolated involvement of adrenals– Multiorgan involvement

• Type I : autosomal recessive associated with mutation on immune regulator gene on Chr. 21

• Type II : multifactorial, linked to HLA-B8 , HLA-DR3 , HLA-DQ5

– Include Hashimoto’s thyroiditis,adrenalitis, diabetes type I, pernicious anemia

Page 187: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

MEN SYNDROME :

• Inherited syndrome with multiple endocrine tumors & or hyperplasia of component cells

• Tumors occur at younger age• Often preceded by asymptomatic OR symptomatic

hyperplasia in involved organ• Tumors may be multifocal in the same organ • Often more aggressive than the same tumor without MEN syndrome

Page 188: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Types of MEN syndromes :

• Type MEN 1 : ( 3 Ps)• Autosomal dominant• Involves suppressor gene on 11q.13

– Parathyroid : multiglandular parathyroid hyperplasia (95%]

– Pancreas: aggressive,multifocal functional gastrinomas & insulinomas

– Pituitary: Prolactinoma ± GH

Page 189: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path

Type MEN 2 :• Autosomal dominant Proto-oncogen mutation : RET/10q 11• MEN 2 A :

– Medullary carcinoma of thyroid + C cell hyperplasia– Pheochromocytoma (50%)– Parathyroid hyperplasia

• MEN 2 B :– As above but no parathyroid hyperplasia – Extra endocrine manifestations : e.g. mucosal neurofibromas

Page 190: PATHOLOGY OF ENDOCRINE SYSTEM 2009 Dr. Huda M Zahawi, FRC.Path